StockData
GSK plc logo

GSK plc (GSK) stock

GSKNYSEPharmaceutical PreparationsAlso trades as GLAXF
Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30
$49.24−1.17 (-2.32%)

Close on Nov 17, 2026Market cap $106.25BP/E 13.4Yield –

GSK total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

GSK's total debt was £17.72B at Dec 31, 2025. For fiscal 2025 it was £17.72B, up 4.3% from the year before. The highest annual figure on record is £30.51B in fiscal 2019.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025£17.72B+4.3%
FY2024Dec 31, 2024£16.99B-5.7%
FY2023Dec 31, 2023£18.02B-14.1%
FY2022Dec 31, 2022£20.99B-13.2%
FY2021Dec 31, 2021£24.17B-11.0%
FY2020Dec 31, 2020£27.15B-11.0%
FY2019Dec 31, 2019£30.51B+17.1%
FY2018Dec 31, 2018£26.06B+52.5%
FY2017Dec 31, 2017£17.09B-9.1%
FY2016Dec 31, 2016£18.79B–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025£17.72B-26.7%
Q4 FY2024Dec 31, 2024£16.99B-37.4%
Q4 FY2023Dec 31, 2023£18.02B-40.9%
Q4 FY2022Dec 31, 2022£20.99B-19.5%
Q4 FY2021Dec 31, 2021£24.17B+41.5%
Q4 FY2020Dec 31, 2020£27.15B+44.5%
Q4 FY2019Dec 31, 2019£30.51B–
Q4 FY2018Dec 31, 2018£26.06B–
Q4 FY2017Dec 31, 2017£17.09B–
Q4 FY2016Dec 31, 2016£18.79B–

More GSK figures

See a number that looks wrong?